Continuous subcutaneous levodopa/ carbidopa infusion for Parkinson's disease: 3-year data from the BeyoND study

被引：0
作者：
Poewe, W. [1 ]
Stocchi, F. [2 ]
Adar, L. [3 ]
Sopromadze, S. [3 ]
Yardeni, T. [3 ]
Giladi, N. [4 ]
机构：
[1] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[2] Univ & Inst Res & Med Care, IRCCS San Raffaele, Rome, Italy
[3] NeuroDerm Ltd, Rehovot, Israel
[4] Tel Aviv Univ, Neurol Inst, Sagol Sch Neurosci, Sackler Sch Med,Tel Aviv Med Ctr, Tel Aviv, Israel
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-282
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
[31]   Subcutaneous Levodopa Infusion for Parkinson's disease Patients with Motor Fluctuations: Open-Label Efficacy Outcomes from the BeyoND study [J].
Poewe, W. ;
Stocchi, F. ;
Adar, L. ;
Case, R. ;
Yardeni, T. ;
Espay, A. .
MOVEMENT DISORDERS, 2021, 36 :S191-S191
[32]   Multi-year Safety and Durability of PEG-J Used for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel in Ambulatory Parkinson's Disease Patients: Year 2 and Beyond [J].
Vanagunas, Arvydas ;
Draganov, Peter ;
Schmulewitz, Nathan ;
Epstein, Michael ;
Hawes, Robert ;
Johnson, David ;
Benesh, Janet A. ;
Chatamra, Krai ;
Eaton, Susan ;
Facheris, Maurizio F. ;
Hall, Coleen M. ;
Robieson, Weining .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 :S150-S151
[33]   Continuous levodopa/carbidopa gel therapy improves dyskinesias in Parkinson's disease [J].
Fox, T. ;
Honig, H. ;
Fox, K. ;
Chauduri, R. ;
Antonini, A. ;
Martinez-Martin, P. ;
Leimbach, S. ;
Odin, P. .
MOVEMENT DISORDERS, 2009, 24 :S264-S264
[34]   Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease - A randomized, crossover infusion study [J].
Senek, M. ;
Nyholm, D. .
MOVEMENT DISORDERS, 2016, 31 :S621-S622
[35]   Levodopa/carbidopa intestinal gel infusion can improve camptocormia in Parkinson's disease [J].
Morales-Briceno, Hugo ;
Mahant, Neil ;
Duma, Stephen ;
Martin, Andrew ;
Griffith, Jane ;
Tsui, David ;
Fung, Victor S. C. .
PARKINSONISM & RELATED DISORDERS, 2019, 65 :282-283
[36]   Levodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age [J].
Morgante, Francesca ;
Oppo, Valentina ;
Fabbri, Margherita ;
Olivola, Enrica ;
Sorbera, Chiara ;
De Micco, Rosa ;
Ielo, Giovanna Chiara ;
Colucci, Fabiana ;
Bonvegna, Salvatore ;
Novelli, Alessio ;
Modugno, Nicola ;
Sensi, Mariachiara ;
Zibetti, Maurizio ;
Lopiano, Leonardo ;
Tessitore, Alessandro ;
Pilleri, Manuela ;
Cilia, Roberto ;
Elia, Antonio E. ;
Eleopra, Roberto ;
Ricciardi, Lucia ;
Cossu, Giovanni .
JOURNAL OF NEUROLOGY, 2021, 268 (05) :1728-1737
[37]   Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study [J].
Zibetti, Maurizio ;
Merola, Aristide ;
Ricchi, Valeria ;
Marchisio, Alice ;
Artusi, Carlo Alberto ;
Rizzi, Laura ;
Montanaro, Elisa ;
Reggio, Dario ;
De Angelis, Claudio ;
Rizzone, Mario ;
Lopiano, Leonardo .
JOURNAL OF NEUROLOGY, 2013, 260 (01) :105-114
[38]   Transcutaneous Port for Continuous Duodenal Levodopa/Carbidopa Administration in Parkinson's Disease [J].
Meppelink, Anne Marthe ;
Nyman, Rickard ;
van Laar, Teus ;
Drent, Martje ;
Prins, Ted ;
Leenders, Klaus Leonhard .
MOVEMENT DISORDERS, 2011, 26 (02) :331-334
[39]   Continuity and presence of side effects of continuous subcutaneous apomorphine infusion and levodopa-carbidopa intestinal gel infusion in advanced Parkinson's disease, in a movement disorder unit in Spain [J].
Muro Garcia, I. ;
Alonso Maroto, J. ;
Gonzalez Garcia, B. ;
Carabajal Pendon, E. ;
Casas, E. ;
Lopez Manzanares, L. .
MOVEMENT DISORDERS, 2023, 38 :S616-S617
[40]   Long-term duodenal levodopa infusion in Parkinson’s disease: a 3-year motor and cognitive follow-up study [J].
Maurizio Zibetti ;
Aristide Merola ;
Valeria Ricchi ;
Alice Marchisio ;
Carlo Alberto Artusi ;
Laura Rizzi ;
Elisa Montanaro ;
Dario Reggio ;
Claudio De Angelis ;
Mario Rizzone ;
Leonardo Lopiano .
Journal of Neurology, 2013, 260 :105-114
12345